Dec 29, 2016 by Brian Orelli, PhDBiotech Stocks: What to Watch in 2017Catalysts in 2017 could give these biotech stocks a boost.
Dec 29, 2016 by Brian Orelli, PhDWhy Cempra Got Slaughtered TodayThe pharmaceutical company received an FDA rejection of the worst kind.
Dec 27, 2016 by Brian Orelli, PhDWhy Seattle Genetics, Inc. Got Clobbered TodayThe FDA places multiple clinical trials run by the biotech on clinical hold.
Dec 21, 2016 by Brian Orelli, PhDChristmas Came Early for These Biotech StocksNo lumps of coal for these drugmakers.
Dec 20, 2016 by Brian Orelli, PhDWhy Cempra Inc. Got Hammered Down TodayThe biotech receives an analyst downgrade ahead of an FDA decision.
Dec 20, 2016 by Brian Orelli, PhDWhy Akebia Therapeutics Inc Stock Zoomed Higher TodayA deal with Otsuka lines the biotech's pockets with cash to fund development of its lead drug.
Dec 16, 2016 by Brian Orelli, PhDWhy Agios Pharmaceuticals Inc. Got Hammered TodayThe biotech is left without a backup plan.
Dec 15, 2016 by Brian Orelli, PhDHow Risky Is Gilead Sciences Inc.?Evaluating the big biotech's likelihood of falling further.
Dec 15, 2016 by Brian Orelli, PhDCelldex Therapeutics, Inc.'s Biggest Failure in 2016A clinical trial called ACT IV appears to be Rintega's last act.
Dec 13, 2016 by Brian Orelli, PhDCantel Medical Corp. Takes Its First Step Towards DoublingThe infection-prevention specialist posts a solid first quarter into the company's five-year strategic plan to double sales and profits.
Dec 12, 2016 by Brian Orelli, PhDWhy Depomed Inc. Got Wacked TodayIt's painful for shareholders when M&A hopes die.
Dec 9, 2016 by Brian Orelli, PhDWhy Emergent Biosolutions Inc. Stockpiled a Higher Price TodayThe biodefense specialist finally has a signed contract with the CDC.
Dec 8, 2016 by Brian Orelli, PhDWhat Happened to Marijuana Stocks in 2016?It was a banner year for companies developing drugs associated with compounds found in marijuana.
Dec 8, 2016 by Brian Orelli, PhDThe 3 Best Biotech Stocks for 2017 These biotech stocks could shine next year.
Dec 7, 2016 by Brian Orelli, PhDWhy bluebird bio Inc. Slipped Lower TodayA dilutive stock offering and comments from President-elect Donald Trump had the biotech's shares trading lower.
Dec 5, 2016 by Brian Orelli, PhDWhy Agios Pharmaceuticals Inc Stock Fell Sharply TodayThe biotech is the big loser from the American Society of Hematology meeting.
Dec 5, 2016 by Brian Orelli, PhDBiotech's Dumbest CEO Moves in 2016The industry leaders' mistakes are lessons for investors.
Dec 1, 2016 by Brian Orelli, PhDHere's the Best Dividend Stock in Big PharmaTo be best, a drugmaker needs more than just a large dividend.
Dec 1, 2016 by Brian Orelli, PhDGilead Sciences, Inc.'s $10 Billion MistakeThe biotech's worst purchase of 2016.
Nov 23, 2016 by Brian Orelli, PhDWhy Juno Therapeutics Inc Plummeted TodayAnother clinical hold on one of the biotech's CAR-T clinical trials has investors hitting the sell button.
